Login / Signup

RBM3 Accelerates Wound Healing of Skin in Diabetes through ERK1/2 Signaling.

Jian-Guo FengMenghong LongXin ZhaoPijun YanYunxiao LinMaohua WangWenhua Huang
Published in: Current molecular pharmacology (2023)
RBM3 activated the ERK1/2 signal to facilitate skin wound healing in diabetes, offering a novel therapeutic target for its treatment.
Keyphrases
  • wound healing
  • type diabetes
  • signaling pathway
  • cardiovascular disease
  • glycemic control
  • cell proliferation
  • pi k akt
  • metabolic syndrome
  • combination therapy
  • insulin resistance
  • skeletal muscle
  • soft tissue